Summary of findings 1: PLD with chemotherapy vs alternative combination chemotherapy
QoL · platinum‐sensitive recurrent EOC
1 finding from 1 review
- Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 608 participantsLow